BC PharmaCare Coverage Discriminatory to Adults with ADHD

Juanita Beaudry

New BC PharmaCare Coverage Discriminatory to Adults with ADHD

On April 18th BC PharmaCare announced that it was expanding its existing coverage of medications for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in the paediatric population only. Three long acting ADHD medications (Adderall XR, Vyvanse and Strattera) will be added under the Special Authority (SA) program. CADDRA and CADDAC along with BC medical practitioners welcome these expanded medication options for children. However, British Columbia continues to lag significantly behind other provinces by denying coverage to individuals over 19, thereby discriminating against adults with ADHD.

Read More on our Blog
May 2, 2017 Media Releases

Latest Blog Posts

Finding a Career You Love When You Have ADHD

If you’re an adult with ADHD, your skills and weak... Read More

Workshop: ADHD in the Workplace

Workshop Request Form While those with Attention D... Read More

How HR professionals can help employees with ADHD

Many adults with ADHD can perform their jobs succe... Read More

Why Does ADHD Still Not Get the Respect It Deserves? By Alison Brazier, Ph.D.

Alison is a mother of an ADHD teenager, a health s... Read More

I Am a Teacher with ADHD, Autism, Depression, and Anxiety by Amber

When I was 3 years old, I was expelled from presch... Read More

Share The Love

linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram